Preserved sensitivity to β2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 8, 2006, Pages 2878-2881

  De Galan, Bastiaan E ^a   De Mol, Pieter ^a   Wennekes, Lianne ^a   Schouwenberg, Bas J J ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; INSULIN; SALBUTAMOL; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIAGNOSTIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOREARM BLOOD FLOW; HEART RATE; HUMAN; HYPOGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; VEIN OCCLUSION PLETHYSMOGRAPHY; AWARENESS; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG POTENTIATION; FOREARM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; VASCULARIZATION; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; AWARENESS; DIABETES MELLITUS, TYPE 1; FEMALE; FOREARM; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN; MALE; MIDDLE AGED; RECEPTORS, ADRENERGIC, BETA-2; SEX CHARACTERISTICS; VASODILATION;

EID: 33747712599     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0528     Document Type: Article

References (24)

1. Cryer PE 2002 Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45:937-948
2. Saleh TY, Cryer PE 1997 Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 20:1231-1236
3. Wiethop BV, Cryer PE 1993 Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 16:1131-1136
4. Berlin I, Grimaldi A, Landault C, Zoghbi F, Thervet F, Puech AJ, Legrand JC 1988 Lack of hypoglycemic symptoms and decreased β-adrenergic sensitivity in insulin-dependent diabetic patients. J Clin Endocrinol Metab 66:273-278
5. Trovik TS, Jaeger R, Jorde R, Sager G 1994 Reduced sensitivity to β-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness. Br J Clin Pharmacol 38:427-432
6. Korytkowski MT, Mokan M, Veneman TF, Mitrakou A, Cryer PE, Gerich JE 1998 Reduced β-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness. Diabetes Care 21:1939-1943
7. Fritsche A, Stefan N, Haring H, Gerich J, Stumvoll M 2001 Avoidance of hypoglycemia restores hypoglycemia awareness by increasing β-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 134:729-736
8. Fritsche A, Stumvoll M, Grub M, Sieslack S, Renn W, Schmulling RM, Haring HU, Gerich JE 1998 Effect of hypoglycemia on β-adrenergic sensitivity in normal and type 1 diabetic subjects. Diabetes Care 21:1505-1510
9. Trovik TS, Vaartun A, Jorde R, Sager G 1995 Dysfunction in the β2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia. Eur J Clin Pharmacol 48:327-332
10. Schwab KO, Menche U, Schmeisl G, Lohse MJ 2004 Hypoglycemia-dependent β2-adrenoceptor downregulation: a contributing factor to hypoglycemia unawareness in patients with type 1 diabetes? Horm Res 62:137-141
11. Enoksson S, Caprio SK, Rife F, Shulman GI, Tamborlane WV, Sherwin RS 2003 Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia. J Clin Endocrinal Metab 88:1503-1511
12. Wallgren F, Amberg G, Hickner RC, Ekelund U, Jorfeldt L, Henriksson J 1995 A mathematical model for measuring blood flow in skeletal muscle with the microdialysis ethanol technique. J Appl Physiol 79:648-659
13. Brakkee AJ, Vendrik AJ 1966 Strain-gauge plethysmography; theoretical and practical notes on a new design. J Appl Physiol 21:701-704
14. Ewing DJ, Clarke BF 1982 Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916-918
15. Clarke WL, Cox DJ, Gonder Frederick LA, Julian D, Schlundt D, Polonsky W 1995 Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18:517-522
16. de Galan BE, Tack CJ, Lenders JW, Pasman JW, Elving LD, Russel FG, Lutterman JA, Smits P 2002 Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes 51:790-796
17. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL 1991 Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87:2246-2252
18. van Tits LJ, Michel MC, Grosse-Wilde H, Happel M, Eigler FW, Soliman A, Brodde OE 1990 Catecholamines increase lymphocyte β2-adrenergic receptors via a β2-adrenergic, spleen-dependent process. Am J Physiol 258:E191-E202
19. Tack CJ, Heeremans M, Thien T, Lutterman JA, Smits P 1996 Regional hyperinsulinemia induces vasodilation but does not modulate adrenergic responsiveness in humans. J Cardiovasc Pharmacol 28:245-251
20. DeSouza CA, Clevenger CM, Greiner JJ, Smith DT, Hoetzer GL, Shapiro LF, Stauffer BL 2002 Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans. J Physiol 542:255-262
21. Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM 2000 Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 36:1233-1238
22. Brodde OE 1990 Physiology and pharmacology of cardiovascular catecholamine receptors: implications for treatment of chronic heart failure. Am Heart J 120:1565-1572
23. Weston PJ, James MA, Panerai R, McNally PG, Potter JF, Thurston H, Swales JD 1996 Abnormal baroreceptor-cardiac reflex sensitivity is not detected by conventional tests of autonomic function in patients with insulin-dependent diabetes mellitus. Clin Sci (Lond) 91:59-64
24. Ferrer MT, Kennedy WR, Sahinen F 1991 Baroreflexes in patients with diabetes mellitus. Neurology 41:1462-1466